Hogan Lovells Publications | Hogan Lovells | 25 April 2016

New VA policy regarding TAA non-compliant covered drugs

The Department of Veterans Affairs (VA) recently announced a fundamental shift in policy that will now require manufacturers to list Veterans Health Care Act (VHCA) covered drugs (i.e., innovators) on Federal Supply Schedule (FSS) contracts, even where the country of origin of the covered drug is a non-designated country under the Trade Agreements Act (TAA).

Read More: New VA Policy Regarding TAA Non-Compliant Covered Drugs

Download PDF Back To Listing